ASH Registry Offers Insights on COVID-19 in Patients with Hematologic Malignancies.

Oncologist ; 26 Suppl 1: S17-S18, 2021 02.

Article in English | MEDLINE | ID: covidwho-996273

Subject(s)

COVID-19/epidemiology; Hematologic Neoplasms/complications; Registries/statistics & numerical data; SARS-CoV-2/immunology; Adult; Age Factors; Aged; Antiviral Agents/therapeutic use; COVID-19/diagnosis; COVID-19/immunology; COVID-19/virology; COVID-19 Testing/statistics & numerical data; Female; Hematologic Neoplasms/immunology; Hematologic Neoplasms/therapy; Hematology/statistics & numerical data; Hospitalization/statistics & numerical data; Humans; Intensive Care Units/statistics & numerical data; Male; Middle Aged; Mortality; Prevalence; Risk Assessment/methods; Risk Assessment/statistics & numerical data; Risk Factors; SARS-CoV-2/isolation & purification; Severity of Illness Index; Societies, Scientific/statistics & numerical data; Survival Analysis; United States/epidemiology; Young Adult; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Registries / Hematologic Neoplasms / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: North America Language: English Journal: Oncologist Journal subject: Neoplasms Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google